PMID- 26747710 OWN - NLM STAT- MEDLINE DCOM- 20160808 LR - 20240326 IS - 1470-8728 (Electronic) IS - 0264-6021 (Print) IS - 0264-6021 (Linking) VI - 473 IP - 6 DP - 2016 Mar 15 TI - Loss of neutral ceramidase protects cells from nutrient- and energy -deprivation-induced cell death. PG - 743-55 LID - 10.1042/BJ20150586 [doi] AB - Sphingolipids are a family of lipids that regulate the cell cycle, differentiation and cell death. Sphingolipids are known to play a role in the induction of apoptosis, but a role for these lipids in necroptosis is largely unknown. Necroptosis is a programmed form of cell death that, unlike apoptosis, does not require ATP. Necroptosis can be induced under a variety of conditions, including nutrient deprivation and plays a major role in ischaemia/reperfusion injury to organs. Sphingolipids play a role in ischaemia/reperfusion injury in several organs. Thus, we hypothesized that sphingolipids mediate nutrient-deprivation-induced necroptosis. To address this, we utilized mouse embryonic fibroblast (MEFs) treated with 2-deoxyglucose (2DG) and antimycin A (AA) to inhibit glycolysis and mitochondrial electron transport. 2DG/AA treatment of MEFs induced necroptosis as it was receptor- interacting protein (RIP)-1/3 kinase-dependent and caspase-independent. Ceramides, sphingosine (Sph) and sphingosine 1-phosphate (S1P) were increased following 2DG/AA treatment. Cells lacking neutral ceramidase (nCDase(-/-)) were protected from 2DG/AA. Although nCDase(-/-) cells generated ceramides following 2DG/AA treatment, they did not generate Sph or S1P. This protection was stimulus-independent as nCDase(-/-) cells were also protected from endoplasmic reticulum (ER) stressors [tunicamycin (TN) or thapsigargin (TG)]. nCDase(-/-) MEFs had higher autophagic flux and mitophagy than wild-type (WT) MEFs and inhibition of autophagy sensitized them to necroptosis. These data indicate that loss of nCDase protects cells from nutrient- deprivation-induced necroptosis via autophagy, and clearance of damaged mitochondria. Results suggest that nCDase is a mediator of necroptosis and might be a novel therapeutic target for protection from ischaemic injury. CI - (c) 2016 Authors; published by Portland Press Limited. FAU - Sundaram, Kumaran AU - Sundaram K AD - Department of Pharmacology & Toxicology, University of Louisville, Louisville, KY 40202, U.S.A. FAU - Mather, Andrew R AU - Mather AR AD - University of South Carolina Medical School, Columbia, SC 29209, U.S.A. FAU - Marimuthu, Subathra AU - Marimuthu S AD - Department of Pharmacology & Toxicology, University of Louisville, Louisville, KY 40202, U.S.A. FAU - Shah, Parag P AU - Shah PP AD - Department of Pharmacology & Toxicology, University of Louisville, Louisville, KY 40202, U.S.A. James Graham Brown Cancer Center, University of Louisville, KY 40202, U.S.A. FAU - Snider, Ashley J AU - Snider AJ AD - Department of Medicine, Stony Brook Cancer Center, Stony Brook University, NY 11794, U.S.A. parallelNorthport Veterans Affairs Medical Center, Northport, NY 11768, U.S.A. FAU - Obeid, Lina M AU - Obeid LM AD - Department of Medicine, Stony Brook Cancer Center, Stony Brook University, NY 11794, U.S.A. parallelNorthport Veterans Affairs Medical Center, Northport, NY 11768, U.S.A. FAU - Hannun, Yusuf A AU - Hannun YA AD - Department of Medicine, Stony Brook Cancer Center, Stony Brook University, NY 11794, U.S.A. FAU - Beverly, Levi J AU - Beverly LJ AD - Department of Pharmacology & Toxicology, University of Louisville, Louisville, KY 40202, U.S.A. James Graham Brown Cancer Center, University of Louisville, KY 40202, U.S.A. Department of Medicine, University of Louisville, KY 40202, U.S.A. FAU - Siskind, Leah J AU - Siskind LJ AD - Department of Pharmacology & Toxicology, University of Louisville, Louisville, KY 40202, U.S.A. James Graham Brown Cancer Center, University of Louisville, KY 40202, U.S.A. leah.siskind@louisville.edu. LA - eng GR - I01 BX000156/BX/BLRD VA/United States GR - P01 CA097132/CA/NCI NIH HHS/United States GR - R01 DK093462/DK/NIDDK NIH HHS/United States GR - R01 GM097741/GM/NIGMS NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural DEP - 20160108 PL - England TA - Biochem J JT - The Biochemical journal JID - 2984726R RN - 0 (Lysophospholipids) RN - 11118-72-2 (antimycin) RN - 26993-30-6 (sphingosine 1-phosphate) RN - 642-15-9 (Antimycin A) RN - 9G2MP84A8W (Deoxyglucose) RN - EC 3.5.1.23 (Asah2 protein, mouse) RN - EC 3.5.1.23 (Neutral Ceramidase) RN - NGZ37HRE42 (Sphingosine) SB - IM MH - Animals MH - Antimycin A/analogs & derivatives/pharmacology MH - Cell Death/drug effects/*physiology MH - Cells, Cultured MH - Deoxyglucose/pharmacology MH - Fibroblasts/*drug effects MH - Gene Deletion MH - Gene Expression Regulation, Enzymologic/*physiology MH - Lysophospholipids/metabolism MH - Mice MH - Mice, Knockout MH - Neutral Ceramidase/genetics/*metabolism MH - Sphingosine/analogs & derivatives/metabolism MH - Up-Regulation PMC - PMC5513154 MID - NIHMS769130 OTO - NOTNLM OT - autophagy flux OT - endoplasmic reticulum (ER) stress OT - mitophagy OT - necroptosis OT - neutral ceramidase OT - sphingolipids EDAT- 2016/01/10 06:00 MHDA- 2016/08/09 06:00 PMCR- 2017/07/17 CRDT- 2016/01/10 06:00 PHST- 2015/05/21 00:00 [received] PHST- 2016/01/08 00:00 [accepted] PHST- 2016/01/10 06:00 [entrez] PHST- 2016/01/10 06:00 [pubmed] PHST- 2016/08/09 06:00 [medline] PHST- 2017/07/17 00:00 [pmc-release] AID - BJ20150586 [pii] AID - 10.1042/BJ20150586 [doi] PST - ppublish SO - Biochem J. 2016 Mar 15;473(6):743-55. doi: 10.1042/BJ20150586. Epub 2016 Jan 8.